| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
711,586 | 785,015 | 824,156 | 916,961 | 1,202,388 |
| Cost of Revenue
|
-240,968 | -252,305 | -286,919 | -338,714 | -422,006 |
|
Gross Profit
|
470,618 | 532,710 | 537,237 | 578,247 | 780,382 |
| Selling, General and Administrative Expenses
|
-379,449 | -436,890 | -471,729 | -496,677 | -578,838 |
|
Research and Development Expenses
|
-39,111 | -39,111 | -15,713 | -12,741 | -- |
|
Operating Income/Expenses
|
-437,500 | -476,001 | -487,442 | -509,418 | -578,838 |
|
Total Operating Profit/Loss
|
33,118 | 56,709 | 49,795 | 68,829 | 201,544 |
| Total Net Finance Income/Expense
|
-30,858 | -34,758 | -46,771 | -61,728 | -60,407 |
| Irregular Income/Expenses
|
0 | 0 | -83,094 | -268,846 | -102,222 |
|
Other Income/Expense, Non-Operating
|
-6,026 | -4,908 | 14,072 | 1,201 | 60,060 |
|
Non-Operating Income/Expenses, Total
|
-36,884 | -39,666 | -115,793 | -329,373 | -102,569 |
|
Pretax Income
|
-3,766 | 17,043 | -65,998 | -260,544 | 98,975 |
|
Provision for Income Tax
|
-12,358 | -16,736 | -8,218 | 1,249 | -44,627 |
|
Net Income from Continuing Operations
|
-16,124 | 307 | -74,216 | -259,295 | 54,348 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-16,124 | 307 | -74,216 | -259,295 | 54,348 |
|
Net Income after Non-Controlling/Minority Interests
|
-16,124 | 307 | -74,216 | -259,295 | 54,348 |
|
Net Income Available to Common Stockholders
|
-16,124 | 307 | -74,216 | -259,295 | 54,348 |
|
Diluted Net Income Available to Common Stockholders
|
-16,124 | 307 | -74,216 | -259,295 | 54,348 |
| Basic EPS
|
-0.36 | 0.01 | -2.00 | -7.47 | 1.58 |
| Diluted EPS
|
-0.36 | 0.01 | -2.00 | -7.47 | 1.49 |
|
Basic Weighted Average Shares Outstanding
|
43,973.9500 | 43,621.7960 | 37,142.2710 | 34,723.4910 | 34,336.4930 |
|
Diluted Weighted Average Shares Outstanding
|
44,325.5270 | 44,476.8690 | 37,142.2710 | 34,723.4910 | 36,506.0950 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
27,092 | 51,801 | -19,227 | -198,816 | 159,382 |
|
EBITDA
|
64,904 | 91,260 | 33,562 | -135,565 | 247,774 |
|
Normalized EBITDA
|
124,602 | 151,846 | 162,431 | 187,515 | 333,342 |
|
Normalized Income
|
-2,411.1800 | 17,482.3900 | 18,961.3400 | 30,896.7500 | 146,659.5000 |
|
Total Unusual Items
|
17,358 | 21,741 | 117,946 | 291,650 | 116,850 |
|
Total Unusual Items Excluding Goodwill
|
17,358 | 21,741 | 117,946 | 291,650 | 116,850 |
|
Tax Effect of Unusual Items
|
3,645.1800 | 4,565.6100 | 24,768.6600 | 1,458.2500 | 24,538.5000 |
12/31/2022 - 4/18/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade